SPORE in Cervical Cancer - Project 5: A Phase I Safety and Immunogenicity Study of a HP16- Specific Therapeutic Protein, TA-CIN, Administered Intratumorally During Chemoradiation, in Patients with Inoperable HPV16+ Cervical Cancer

Tzyy-Choou Wu

Upregulation of Nanog as an Innovative Mechanism for Cancer Drug Resistance

Cervix uteri

Richard E Chaisson

The Johns Hopkins Center for AIDS Research (JHU CFAR)

Kaposi sarcoma Colorectum Cervix uteri Brain, nervous system

Maureen Joffe

HIVs Effects on Breast Cancer Treatment and Outcomes in South Africa

Trachea, bronchus and lung Other pharynx Oesophagus Non-Hodgkin lymphoma Nasopharynx Liver and intrahepatic bile ducts Kidney, renal pelvis and ureter Kaposi sarcoma Hodgkin lymphoma Colorectum Cervix uteri Breast

Harold M Swartz

Direct and Repeated Clinical Measurement of pO2 for Enhancing Cancer Therapy

Other pharynx Non-Hodgkin lymphoma Cervix uteri Breast Brain, nervous system

Radiation Oncology

Investigator from Johns Hopkins University

Tissue-based Prediction of Response to Immunotherapy in HPV Disease

Cervix uteri

Sally Roberts

The role of oncogenic HPV E6-PDZ interactions in the viral life cycle and in HPV-induced malignancy

Other pharynx Oesophagus Nasopharynx Lip, oral cavity Larynx Cervix uteri

Mark Schiffman

HPV Kaiser Permanente Northern California

Cervix uteri

Steve Kamiza

Linked: HIV-Associated Malignancies in Malawi

Liver and intrahepatic bile ducts Kaposi sarcoma Cervix uteri

Global Noncommunicable Diseases Intiatives

Improving sexual and reproductive health care of Paraguayan women supporting the National Plan on cervical cancer prevention, Ministry of Public Health

Cervix uteri